V-Lab
Ultragenyx Pharmaceutical Inc MF2-GARCH Volatility Analysis
Volatility prediction for Monday, August 24th, 2026
1 Day
52.62%
decreased by 1.86%
1 Week
54.04%
decreased by 0.44%
1 Month
55.65%
increased by 1.17%
Analysis last updated: Friday, August 21, 2026 at 10:10 PM UTC
News Impact Curve
How returns affect tomorrow's volatilityVolatility Forecast
How volatility evolves over timeParameter Estimates
Jan 31, 2014 to Aug 21, 2026Model Insight
This asset exhibits a strong leverage effect: volatility responds almost entirely to negative shocks. The ARCH response to positive shocks is negligible.
σ
MF2-GARCH Model
Tap to view equation
| Parameter | Value | t-statistic |
|---|---|---|
m window Rolling window length | 126 | |
α ARCH Response to squared shocks | 0.0256 | 2.60*** |
β GARCH Volatility persistence | 0.6473 | 23.24*** |
γ leverage Additional response to negative shocks | 0.1155 | 9.10*** |
λ₁ tau intercept Baseline long-term coefficient | 5.1509 | 0.10 |
λ₂ forecast adj. Forecast performance sensitivity | 0.3129 | 0.10 |
λ₃ tau persistence Long-term factor persistence | 0.2883 | 0.04 |
Persistence:
0.731
Half-life:
2 days
Other Ultragenyx Pharmaceutical Inc Analyses
Other MF2-GARCH Analyses on Equities